Otto S Hoekstra Selected Research

Otto S Hoekstra Research Topics

Disease

69	Neoplasms (Cancer) 01/2023 - 01/2002
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 01/2002
23	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2002
18	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2012
12	Carcinoma (Carcinomatosis) 01/2019 - 09/2004
11	Head and Neck Neoplasms (Head and Neck Cancer) 06/2022 - 09/2004
10	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2002
10	Squamous Cell Carcinoma of Head and Neck 09/2020 - 04/2011
10	Glioma (Gliomas) 01/2020 - 10/2003
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2014
8	Lymphatic Metastasis 01/2020 - 10/2004
6	Rheumatoid Arthritis 01/2020 - 01/2011
6	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 02/2014
5	Lymphoma (Lymphomas) 10/2020 - 04/2006
5	Hypoxia (Hypoxemia) 01/2017 - 01/2002
4	Inflammation (Inflammations) 06/2022 - 04/2012
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2022 - 11/2003
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 06/2012
3	Arthritis (Polyarthritis) 01/2020 - 01/2012
3	Melanoma (Melanoma, Malignant) 11/2019 - 07/2006
3	Body Weight (Weight, Body) 01/2019 - 11/2009
3	Diffuse Intrinsic Pontine Glioma 01/2018 - 01/2014
3	Pain (Aches) 08/2017 - 11/2004
3	Thyroid Neoplasms (Thyroid Cancer) 05/2016 - 06/2014
3	Synovitis 09/2015 - 01/2012
3	Esophageal Neoplasms (Esophageal Cancer) 01/2011 - 09/2005
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 08/2019
2	Lung Neoplasms (Lung Cancer) 02/2022 - 05/2011
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 04/2006
2	Disease Progression 01/2021 - 01/2017
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019 - 02/2013
2	Brain Neoplasms (Brain Tumor) 05/2017 - 01/2014
2	Mouth Neoplasms (Oral Cancer) 02/2017 - 04/2013
2	Margins of Excision 02/2016 - 11/2007
2	Adenocarcinoma 01/2016 - 02/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2012 - 04/2012
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2011 - 05/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2008 - 09/2007

Drug/Important Bio-Agent (IBA)

42	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 04/2002
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2006
14	Glucose (Dextrose)FDA LinkGeneric 10/2016 - 01/2002
8	AntigensIBA 01/2021 - 01/2016
5	Monoclonal AntibodiesIBA 03/2022 - 10/2015
5	fluoromethylcholineIBA 10/2017 - 01/2012
4	Androgen Receptors (Androgen Receptor)IBA 07/2019 - 12/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2002
4	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2011
4	Deoxyglucose (2 Deoxy D glucose)IBA 08/2014 - 12/2011
3	Rituximab (Mabthera)FDA Link 10/2020 - 01/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 07/2018
3	Choline (Choline Chloride)IBA 06/2019 - 05/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2015
3	AlbuminsIBA 02/2018 - 10/2011
3	Docetaxel (Taxotere)FDA Link 08/2017 - 02/2013
3	alovudineIBA 08/2017 - 12/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 01/2011
3	Fluorine-18IBA 08/2014 - 08/2002
3	Thallium-201IBA 06/2012 - 10/2003
2	G250 monoclonal antibodyIBA 01/2023 - 08/2019
2	B7-H1 AntigenIBA 03/2022 - 01/2022
2	89Zr-rituximabIBA 02/2022 - 01/2017
2	Estrogen ReceptorsIBA 10/2021 - 12/2017
2	Polyvinyl Chloride (PVC)IBA 01/2021 - 11/2017
2	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 01/2021 - 12/2019
2	Prednisone (Sone)FDA LinkGeneric 10/2020 - 08/2017
2	LigandsIBA 10/2020 - 10/2018
2	GadoliniumIBA 01/2020 - 10/2016
2	89Zr-bevacizumabIBA 01/2018 - 05/2017
2	RadiopharmaceuticalsIBA 08/2017 - 01/2016
2	dipinacoline glutamateIBA 05/2017 - 01/2014
2	Thyroglobulin FDA Link 05/2016 - 06/2014
2	Immunoconjugates (Immunoconjugate)IBA 04/2016 - 01/2016
2	Aurora Kinase AIBA 01/2016 - 01/2016
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2016 - 12/2006
2	Cetuximab (Erbitux)FDA Link 01/2016 - 10/2015
2	PK 11195 (PK11195)IBA 09/2015 - 04/2012
2	cabazitaxel FDA Link 06/2015 - 02/2013
2	Technetium (Technetium 99m)IBA 02/2013 - 09/2007
2	CalciumIBA 04/2012 - 04/2012
1	pembrolizumabIBA 03/2022
1	durvalumabIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	Vincristine (Oncovin)FDA LinkGeneric 10/2020
1	NivolumabIBA 10/2020
1	BMS-986192IBA 10/2020
1	16-fluoroestradiolIBA 04/2020

Therapy/Procedure

30	Therapeutics 01/2021 - 01/2002
19	Radiotherapy 06/2022 - 09/2004
11	Chemoradiotherapy 06/2022 - 07/2008
11	Drug Therapy (Chemotherapy) 06/2015 - 10/2002
7	Castration 07/2019 - 01/2016
5	Neck Dissection (Radical Neck Dissection) 02/2017 - 10/2004
4	Neoadjuvant Therapy 01/2011 - 09/2005
3	General Anesthesia 02/2016 - 11/2007
3	Laryngectomy 02/2016 - 11/2007
3	Aftercare (After-Treatment) 11/2014 - 10/2010
3	Thoracotomy 04/2006 - 04/2002
2	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 11/2002